| 英文名称 | 中文名称 | CAS | MF |
|
N,N'-(4-METHYL-M-PHENYLENE)BIS(P-TOLUENESULFONAMIDE)
|
|
|
C21H22N2O4S2
|
|
N,N''-(methylenedi-4,1-phenylene)bis N'-cyclohexyl-Urea
|
N,N''-(亚甲基二-4,1-亚苯基)二[N'-环己基脲]
|
58890-25-8
|
C27H36N4O2
|
|
N,N'-(methylenedi-4,1-phenylene)bis[dibenzylamine]
|
|
69595-64-8
|
C41H38N2
|
|
N,N'-(4-METHYL-M-PHENYLENE)DIACETAMIDE
|
|
|
C11H12NO2
|
|
N-[[N-METHYL-N-[(2-ISOPROPYL-1,1,1,3,3,3-D6)-4-THIAZOLYL]METHYL]AMINO]CARBONYL-L-VALINE METHYL ESTER
|
|
|
C15H19D6N3O3S
|
|
N-(N'-(2-(4'-methylmorpholinio)ethyl)-N''-cyclohexylguanyl)amphotericin B methyl ester
|
|
79451-27-7
|
C62H101N4O18+
|
|
N(5),N(10)-methylene-tetrahydromethanopterin
|
|
|
|
|
N-(3-(2-(N'-(2-methoxyethyl)guanidino)thiazol-4-yl)benzyl)acetamide
|
|
|
|
|
N,N"-(methylenedi-4,1-phenylene)bis[N'-phenyl-Urea]
|
N,N'-(亚甲基二-4,1-亚苯基)二[N'-苯基脲]
|
13140-83-5
|
C27H24N4O2
|
|
N,N'-METHYLENEBISMETHACRYLAMIDE
|
N,N'-亚甲基双甲基丙烯胺
|
2359-15-1
|
C9H14N2O2
|
|
N-(4-{N-[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]ethanehydrazonoyl}phenyl)methanesulfonamide
|
|
522594-12-3
|
C20H20N4O4S
|
|
N-(4-{N-[(4-methoxyphenyl)sulfonyl]ethanehydrazonoyl}phenyl)-2-methylbenzamide
|
|
|
C23H23N3O4S
|
|
N6-[6-((N-METHYL-ANTHRANILOYL)-AMINO)]HEXYL-ADENOSINE-5'-TRIPHOSPHATE, SODIUM SALT
|
|
|
C24H33N7Na3O14P3
|
|
N,Nμ-(Methylenediphenylene)bis{4-(2-pyridinyl)-1-piperazinecarboxamide} (derivative of 4,4μ-MDIP)
|
N,N′-(亚甲基二亚苯基)双{4-(2-吡啶基)-1-哌嗪甲酰胺}(4,4′-MDIP 的衍生物)
|
|
|
|
N,N'-(Methylenedi-4,1-phenylene)bis[n-(oxiranyl methyl)oxiranemethanmanine],homopolymer
|
N,N'-(二亚甲基-4,1-亚苯基)[N-(环氧乙基甲基)]环氧乙烷甲胺的均聚物
|
31305-94-9
|
C25H30N2O4
|
|
N-[[N-METHYL-N-[(2-ISOPROPYL)-4-THIAZOLYL]METHYL]AMINO]CARBONYL-L-VALINE CARBOXYLIC ACID
|
|
|
C14H23N3O3S
|
|
N'-(N-methyl-4-piperidyl)acetohydrazide
|
|
2799-92-0
|
C8H17N3O
|
|
N,N''-(methyl-m-phenylene)bis[N'-benzylurea]
|
|
94248-10-9
|
C23H24N4O2
|
|
N,N'-methylenebishexadecan-1-amide
|
N,N'-亚甲基双十六碳-1-酰胺
|
5136-47-0
|
C33H66N2O2
|
|
N,N'-(4-Methyl-1,3-phenylene)bis(1-pyrrolidinecarboxamide)
|
N,N'-(4-甲基-1,3-亚苯基)二(1-吡咯烷甲酰胺)
|
60006-11-3
|
C17H24N4O2
|
|
N-(4-{N-[(1-methyl-1H-pyrazol-3-yl)carbonyl]ethanehydrazonoyl}phenyl)cyclobutanecarboxamide
|
|
490014-39-6
|
C18H21N5O2
|
|
N-(4-{N-[(7-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-3-yl)carbonyl]ethanehydrazonoyl}phenyl)isonicotinamide
|
|
514839-85-1
|
C28H23N7O2
|
|
N-(3-{N-[(1-methyl-1H-pyrazol-3-yl)carbonyl]ethanehydrazonoyl}phenyl)isonicotinamide
|
|
515151-10-7
|
C19H18N6O2
|
|
N-{4-[N-(2-methyl-3-furoyl)ethanehydrazonoyl]phenyl}cyclopentanecarboxamide
|
|
495386-57-7
|
C20H23N3O3
|
|
N-(4-{N-[(4-methylphenyl)sulfonyl]ethanehydrazonoyl}phenyl)propanamide
|
|
445008-41-3
|
C18H21N3O3S
|
|
N,N"-(methylene-1,3-phenylene) bis[N'-(octyl-Urea
|
N,N"-(亚甲基二-1,3-亚苯基)二[N'-(辛基)脲]
|
53758-85-3
|
|
|
nobotanin I
|
|
113900-94-0
|
C89H58O56
|
|
nobotanin E
|
|
113866-94-7
|
C123H84O78
|
|
N5,N10-methenyltetra-hydrofolic acid
|
N5,N10-次甲四氫葉酸
|
|
C20H22N7O6
|
|
N-N'-(methylene-p-phenylene)bis(beta-alaninohydrazide)
|
|
93893-46-0
|
C19H26N6O2
|
|
N''-[N-METHOXYCARBONYL-L-VALYL]-N-[(S)-3,3,3-TRIFLUOR-1-ISOPROPYL-2-OXOPROPYL]-L-PROLINAMIDE
|
182073-77-4
|
182073-77-4
|
C18H28F3N3O5
|
|
N,N'-METHYLENEBIS(METHYL CARBAMATE)
|
|
5937-53-1
|
C5H10N2O4
|
|
N-(N'-methyl-N-(9 beta-D-ribofuranosylpurin-6-yl)carbamyl)threonine
|
|
39667-81-7
|
C16H22N6O8
|
|
N,N'-[[(1-methylethyl)imino]bis[(2-hydroxy-3,1-propanediyl)oxy-4,1-phenylene]]bisacetamide
|
|
68959-60-4
|
C25H35N3O6
|
|
N,N'-(Methylenediphenylene)bis{4-(2-pyridyl)-1-piperazinecarboxamide}
|
|
|
C33H36N8O2
|
|
N,N'-METHYLENE-DI(MANGANESEETHYLENEBISDITHIOCARBAMATE)
|
|
|
|
|
Nobotanin B
|
|
104696-16-4
|
C82H56O52
|
|
6-(N,N-METHYLETHYLAMINO)PYRIDINE-2-BORONIC ACID
|
|
1264153-68-5
|
C8H13BN2O2
|
|
6-(N,N-METHYLETHYLAMINO)PYRIDINE-2-BORONIC ACID PINACOL ESTER
|
|
|
C14H23BN2O2
|
|
N,N'-(4-METHYL-1,3-PHENYLENE)BISMALEIMIDE
|
1,1-(4-甲基-1,3-亚苯基)二-1H-吡咯-2,5-二酮
|
6422-83-9
|
C15H10N2O4
|
|
2-(N,N-METHYLETHYLAMINO)ETHANOL
|
|
|
C5H13NO
|
|
N, N^<'^>-methylene diacrylamide crosslink polyacrylamide high water absorbent resin
|
N, N^<'^>-亚甲基双丙烯酰胺交联聚丙烯酰胺高吸水性树脂
|
|
|
|
N-(3-{N-[(4-methoxyphenyl)acetyl]ethanehydrazonoyl}phenyl)cyclopropanecarboxamide
|
|
543684-85-1
|
C21H23N3O3
|
|
N-{4-[N-({2-methoxy[(4-methylphenyl)sulfonyl]anilino}acetyl)ethanehydrazonoyl]phenyl}benzamide
|
|
528590-48-9
|
C31H30N4O5S
|
|
N-{3-[N-(2-methyl-3-furoyl)ethanehydrazonoyl]phenyl}benzenesulfonamide
|
|
522594-13-4
|
C20H19N3O4S
|
|
N-(4-{N-[(5-methyl-2-thienyl)carbonyl]ethanehydrazonoyl}phenyl)propanamide
|
|
515177-18-1
|
C17H19N3O2S
|
|
N,N'-(methylenedi-p-phenylene)bis(aziridine-1-carboxamide)
|
N,N'-(亚甲基双-P-苯基)双(氮丙啶-1-甲酰胺)
|
7417-99-4
|
C19H20N4O2
|
|
2-(N,N-METHYLETHYLAMINO)THIAZOLE-4-BORONIC ACID
|
|
|
C6H11BN2O2S
|
|
5-(N,N-METHYLETHYLAMINO)PYRAZINE-2-BORONIC ACID
|
|
|
C7H12BN3O2
|
|
NOB-1 protein
|
|
|
|
|
no bridge protein
|
|
|
|
|
N-(O-CHLOROBENZYL)HYDRAZIDE DIHYDROCHLORIDE
|
(2-氯苄基)肼二盐酸盐
|
64415-10-7
|
C7H11Cl3N2
|
|
(+)-N-(o-chlorobenzyl)-alpha-methylphenethylamine hydrochloride
|
氯苄雷司盐酸盐
|
5843-53-8
|
C16H19Cl2N
|
|
N-(O-CHLOROBENZOYL)-DL-METHIONINE
|
|
|
C12H14ClNO3S
|
|
N-(O-CHLOROPHENYL)CROTONAMIDE
|
|
|
C10H10ClNO
|
|
N-(O-CHLOROPHENYL)-4,5-DIHYDRO-3-FURAMIDE
|
|
|
C11H10ClNO2
|
|
N-(O-CHLOROPHENYL)-3-HYDROXY-2-NAPHTHAMIDE
|
|
|
C17H12ClNO2
|
|
N-(O-CHLOROBENZYLOXYCARBONYLOXY)SUCCINIMIDE
|
|
|
C12H10ClNO5
|
|
4-[1-[N-(o-Chlorophenyl)carbamoyl]-2-oxopropylazo]-3-nitrobenzenesulfonic acid sodium salt
|
|
|
C16H12ClN4NaO7S
|
|
N-(o-Chlorophenyl)maleamidic acid
|
|
53616-16-3
|
C10H8ClNO3
|
|
N-(o-Chlorophenyl)-N-(p-chlorophenyl)benzamide
|
|
73688-83-2
|
|
|
N-(o-Chlorophenyl)hydroxylamine
|
|
|
C6H6ClNO
|
|
Nociceptin (1-13) Amide, [Phe1-ψ(CH2-NH)-Gly2]-
|
NOCICEPTIN (1-13) AMIDE, [PHE1-Ψ(CH2-NH)-GLY2]-
|
|
|
|
NOCICEPTIN
|
孤菲肽
|
170713-75-4
|
C79H129N27O22
|
|
NOCICEPTIN (1-13) AMIDE
|
PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-NH2
|
178064-02-3
|
C61H100N22O15
|
|
NOCICEPTIN(TYR14) [TYROSYL 3,5-3H]
|
|
|
C82H124N26O24T2
|
|
NOCICEPTIN RECEPTOR ANTAGONIST PEPTIDE III-BTD
|
|
|
C40H62ClN13O7S
|
|
NOCICEPTIN (TYR14), [125I]-
|
|
|
C82H124I2N26O24
|
|
nociceptin (1-6)
|
|
|
|
|
NOCICEPTIN,RABBITANTI-:RIA
|
|
|
|
|
Nociceptin receptor
|
孤菲肽受体(痛敏肽受体)(抗体)
|
|
|
|
NOCICEPTIN,RABBITANTI-:IH
|
|
|
|
|
nociceptin-(1-13)-NH2, NPhe(1)-
|
|
|
|
|
NOCICEPTIN (1-7)
|
H-PHE-GLY-GLY-PHE-THR-GLY-ALA-OH
|
178249-42-8
|
C31H41N7O9
|
|
NOCICEPTIN,RABBITANTI-,IFKIT
|
|
|
|
|
nociceptin, Tyr(1)-
|
|
|
|
|
nociceptin (1-11)
|
|
|
|
|
nociceptin (1-17)-NH2, Phe(1)-psi(CH2NH)-Gly(2)-
|
|
|
|
|
nociceptin (1-13)-NH2, Phe(1)-psi(CH2-NH)-Gly(2)-
|
|
|
|
|
NOCICEPTIN
|
孤菲肽(痛敏肽)(抗原)
|
|
C79H129N27O22
|
|
NOCICEPTIN [P-3H-PHE1]
|
|
|
C82H125N26O24T
|
|
NOCICEPTIN [LEUCYL 3,4,5-3H]
|
|
|
C79H126N27O22T3
|
|
NociceptinOrphaninFQ
|
N/OFQ
|
|
|
|
NOCICEPTIN (1-13), BODIPY(R) 576/589
|
|
|
|
|
4-NO2 14C6H4OP[S][OCH3]2
|
|
179795-13-2
|
C8H10NO5PS
|
|
NOCHROMIX, GLASS-CLEANING REAGENT
|
|
|
|
|
NOCHROMIXTM
|
|
|
|
|
NocIII neuropeptide
|
|
|
|
|
NocII neuropeptide
|
|
|
|
|
NOCII
|
孤儿神经肽NOCII
|
188119-47-3
|
C92H141N23O28S2
|
|
NO-CHX
|
|
|
|
|
NOCISTATIN
|
GLU-GLN-LYS-GLN-LEU-GLN
|
|
C32H56N10O12
|
|
NOCISTATIN (BOVINE)
|
NOCISTATIN (BOVINE)
|
208253-85-4
|
C82H135N21O32
|
|
NOCISTATIN (HUMAN)
|
诺西他汀(人)
|
212609-11-5
|
C149H238N42O53S3
|
|
N2-[N-(N-acetyl-L-leucyl)-L-leucyl]-L-arginine sulphate
|
|
73655-05-7
|
C20H40N6O9S
|
|
N2-[N-[N-Acetyl 1-O-(2-tetradecylhexadecanoyl)-α-muramoyl]-L-alanyl]-D-isoglutamine methyl ester
|
|
|
|
|
N2-[N-[N-Acetyl-1-[[8-[[(tert-butoxy)carbonyl]amino]octanoyl]thio]-6-[11-[[(tert-butoxy)carbonyl]amino]undecanoyl]muramoyl]-L-alanyl]-D-glutamine methyl ester
|
|
|
C49H86N6O17S
|
|
N2-[N-[N-Acetyl-1-[[8-[[(tert-butoxy)carbonyl]amino]octanoyl]thio]-6-[5-[[(tert-butoxy)carbonyl]amino]pentanoyl]muramoyl]-L-alanyl]-D-glutamine methyl ester
|
|
|
C43H74N6O17S
|
|
N2-[N-[N-Acetyl-4-O,6-O-(dimethylmethylene)-α-muramoyl]-L-alanyl]-D-isoglutamine methyl ester
|
|
|
|
|
N2-[N-[N-Acetyl 4-O,6-O-(dimethylmethylene)-1-deoxy-1-mercapto-β-muramoyl]-L-alanyl]-D-isoglutamine methyl ester
|
|
|
|